Chevy Chase Trust’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-263,693
Closed -$417K 647
2025
Q3
$417K Sell
263,693
-1,459,546
-85% -$2.54M ﹤0.01% 598
2025
Q2
$3.76M Sell
1,723,239
-506,943
-23% -$1.23M 0.01% 537
2025
Q1
$6.09M Buy
2,230,182
+890,353
+66% +$3.51M 0.02% 482
2024
Q4
$5.57M Buy
1,339,829
+7,781
+0.6% +$29.4K 0.02% 497
2024
Q3
$5.18M Buy
1,332,048
+9,488
+0.7% +$40K 0.02% 508
2024
Q2
$5.18M Buy
1,322,560
+26,163
+2% +$113K 0.02% 494
2024
Q1
$5.43M Buy
1,296,397
+1,239,602
+2,183% +$5.82M 0.02% 500
2023
Q4
$267K Buy
56,795
+543
+1% +$2.11K ﹤0.01% 602
2023
Q3
$176K Buy
56,252
+8,871
+19% +$35.7K ﹤0.01% 612
2023
Q2
$217K Buy
+47,381
New +$218K ﹤0.01% 610

Other funds holding MXCT

Chevy Chase Trust's MXCT Position: Q4 2025 in Review

Chevy Chase Trust sold out of MaxCyte (MXCT) in Q4 2025, closing a stake of 263,693 shares — an estimated $417K sold.

Chevy Chase Trust first reported a position in MXCT in Q2 2023 and held it in 10 quarters. The position peaked at $6.09M in Q1 2025. 112 funds tracked by Wall St. Rank hold MXCT as of Q4 2025.

  • Chevy Chase Trust reported no remaining MaxCyte position as of Q4 2025 after selling out during the quarter.
  • Chevy Chase Trust sold 263,693 MaxCyte shares in Q4 2025, an estimated $417K.
  • Chevy Chase Trust first reported a position in MaxCyte in Q2 2023 and held it in 10 quarters.
  • Chevy Chase Trust's MaxCyte position peaked at $6.09M in Q1 2025.
  • 112 funds tracked by Wall St. Rank held MaxCyte as of Q4 2025.

Based on Chevy Chase Trust's 13F filing for Q4 2025, filed 13 Feb 2026.